Altogether these results demonstrate that PRKACA mutations constitutively activate PKA leading to cortisol-producing adenomas, thereby suggesting that PRKACA is a main contributor to adrenocortical tumorigenesis. This evidence concerns the gene PRKACA and adenoma.